IM Cannabis (IMCC) Net Equity Issued and Repurchased (2021 - 2024)

IM Cannabis' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at -$128680.7 for Q2 2024.

• On a quarterly basis, Net Equity Issued and Repurchased fell 120.03% year-over-year to -$128680.7 in Q2 2024; TTM through Jun 2024 was $644393.7, a 84.34% decrease from a year earlier, with the FY2022 full-year figure at $2.9 million, down 87.13% from the prior year.
• Net Equity Issued and Repurchased eased to -$128680.7 in Q2 2024 per IMCC's latest filing, from $130611.9 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $2.4 million in Q3 2022 and bottomed at -$8.9 million in Q4 2021.
• The 4-year median for Net Equity Issued and Repurchased is $428761.1 (2022), against an average of -$683680.1.
• Across the five-year window, Net Equity Issued and Repurchased surged 104.82% in 2022 and slumped 120.03% in 2024, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at -$8.9 million in 2021, then jumped by 104.82% to $428761.1 in 2022, then soared by 49.84% to $642462.5 in 2023, then slumped by 120.03% to -$128680.7 in 2024.
• Per Business Quant, the three latest IMCC Net Equity Issued and Repurchased figures stand at -$128680.7 (Q2 2024), $130611.9 (Q1 2024), and $642462.5 (Q2 2023).